Novasep’s €27m viral vector plant to create up to 100 Belgian jobs
The new viral vector production facility will contain two GMP suites equipped with single-use bioreactors ranging from 200L to 2,000L, says Novasep.
Archives for February 14, 2017
Lilly rejects reports US tax plan prompted Ireland investment rethink
Rumours of an Irish expansion freeze have been greatly exaggerated according to Eli Lilly, which says it remains committed to its Kinsale biomanufacturing site.
Dutch Biopharma launches Phase III trial of Leukemia donor cell therapy
Amsterdam-based Kiadis Biopharma has received Health Canada approval to initiate a global Phase III trial for an allogenic stem cell therapy for acute leukemia.
Orgenesis granted €12.3m for GMP production ahead of clinical trials
Orgenesis’ Belgian subsidiary, Orgenesis SPRL, has received €12.3m ($12.8m) to further develop its Type 1 Diabetes program.
Thermo Fisher bags single-use bioreactor tech partner Finesse
Thermo Fisher Scientific says it is buying Finesse Solutions, its long-term supplier of measurement and control solutions for bioprocessing applications.